responders (p=0.03) and a higher rate of males (p=0.06) as well as pts with previous myocardial infarction (p=0.06) in this group. There were no statistically significant differences in sex, BMI or diabetics. Additional analysis of response versus weight showed an association with Pts weighing less than 75kg who were more likely to be double responders (p=0.02) Conclusion: Combined aspirin and clopidogrel non-responsiveness is found in almost 12% of Pts. The only clinical predictor is weight>75kg.
Methods:
The study included 166 consecutive Pts with CTO's (European CTO Club definition) who underwent primary PCI at our institution between June 2008 and Feb 2010 by 2 experienced operators. The cohort was divided into 2 groups: group 1 (n=83), treated before availability of "Fielder XT" GW in France and group 2 (n=83), treated since availability.
Results: Clinical and angiographic characteristics were similar in both groups (age 63.9±11.3years, lesion length 23.0±18.1mm, bridging collateral 37.%, tortuosity score 0.16±0.37/1 and calcification score 0.94±1.08/3). Fielder XT was used in 1 case (1.2%) in group 1 and 67 (80.7%) in group 2. Micro catheters were used more frequently in group 2 (73.2% vs 56.6%; p=0.013) and parallel wire technique was less required (16.2% vs 31.3%; p=0.011). Angiographic success rate was significantly higher in group 2 (84.3% vs 67.5%; p=0.005) with a lower rate of dissection (12.2% vs 24.7%; p=0.02) and a trend for a lower rate of perforation (4.9% vs 1.2%; p=ns). Predictors of failure in the total cohort were by multivariate logistic regression analysis: proximal tortuosity (p=0.048, OR=3.15), absence of bifurcation (p=0.024, OR=3.39), no visible stump (p<0.0001, OR=6.25), calcification (p=0.029, OR=1.56) and patient in group 1 (p=0.015, OR=3.37).
Conclusion:
Introduction of a dedicated "soft" wire in the CTO treatment strategy improves the angiographic success rate of PCI with a more simple and "soft" technique. Multivariate analysis confirmed classical independent predictors of failure but also demonstrated that a new device may influence success rate.
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Identification of patients at risk for premature discontinuation of oral antiplatelet therapy after elective percutaneous coronary intervention Guillaume Cayla (1), Jean Philippe Collet (2), Johanne Silvain (2), Laurent Schmutz (1), Bertrand Ledermann (1), Jean-Christophe Macia (3), Richard Gervasoni (3) Background: Premature discontinuation of antiplatelet therapy is a major risk factor of stent thrombosis after drug-eluting stent placement leading to an increased risk of death.
Objectives: We sought to determine by a simple questionnaire the prevalence of patients at risk for premature discontinuation of oral antiplatelet therapy in elective percutaneous coronary intervention (PCI).
Methods:
Patients scheduled for elective PCI underwent a routine interview (RI) and a specific questionnaire (SQ) by two independent physicians the day before the intervention. The SQ was designed to identify bleeding disorders, suspected cancer, planned invasive procedures and self evaluation of compliance. The final decision of drug eluting stent (DES) implantation was made by a third independent physician who performed the planned PCI and who had full access to the patient record.
Results: At least one contraindication to DES implantation was found in one third of the study population (82/302, 27%) after the RI. All these patients were also identified by the SQ. At total of 31 additional patients were identified by the SQ as non eligible for DES implantation. Active bleeding (n=14) and scheduled biopsies (n=4) were the two main contraindications to DES implantation isolated by the SQ. Patients characteristics and angiographic findings identified 59.9% patients (n=181/302) eligible for a DES implantation. Finally the physician performing the PCI excluded 66.3% of the patients (n=79/302) who could receive a DES and implanted a bare metal stent (BMS) instead. This decision was based on the findings of the dedicated questionnaire on top of the interview in 30 patients (38%) and in 49 patients (62%) for other reasons.
Conclusions:
In elective PCI, a simple questionnaire used before DES implantation can improve identification of patients at high risk for premature discontinuation of antiplatelet therapy.
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In hospital short and long term prognostic value of homocysteine in patients with ST elevation myocardial infarction
Fathia Mghaieth (1), Ramy Trabelsi (1), Sami Mourali (2), Abdeljelil Farhati (2), Salem Abdessalem (2), Kéchida Zohra (1), Rafik Boussaada (2), Rachid Mechmèche (2) (1) Hôpital la Rabta,Cardiologie, Tunis, Tunisie -(2) Hôpital la Rabta, Tunis, Tunisie Background: Homocysteine has pro-thrombotic and pro-inflammatory properties, it is a risk factor for cardiovascular disease. The prognostic value of homocysteine in ST elevation myocardial infarction (STEMI) remains uncertain. Aim: This study evaluates the predictive role of homocysteine level on short and long term outcome in patients with STEMI. 
Methods and results
